MOORE ALISON

CIK 00017549373 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001754937

Recent Transactions

50 trades

Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2025-11-13+500,000→ 500,000 total
Award
CODEXIS, INC.$CDXS
Common Stock
2025-11-13+85,000→ 254,332 total
Sale
CODEXIS, INC.$CDXS
Common Stock
2025-10-13$2.51/sh−6,239→ 169,332 total
Award
Artiva Biotherapeutics, Inc.$ARTV
Director Stock Option (Right to Buy)
2025-06-24+13,750→ 13,750 total
Award
CODEXIS, INC.$CDXS
Common Stock
2025-02-05+26,875→ 175,571 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2025-02-05+161,250→ 161,250 total
Award
Artiva Biotherapeutics, Inc.$ARTV
Director Stock Option (Right to Buy)
2024-10-21+27,500→ 27,500 total
Award
CODEXIS, INC.$CDXS
Common Stock
2024-10-10+50,000→ 148,696 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2024-10-10+300,000→ 300,000 total
Award
CODEXIS, INC.$CDXS
Common Stock
2024-06-11+30,120→ 98,696 total
Award
CODEXIS, INC.$CDXS
Common Stock
2023-06-13+34,602→ 68,576 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-22+558,094→ 672,731 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2023-03-22+432,738→ 432,738 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-14$5.51/sh−8,351→ 114,637 total
Award
CODEXIS, INC.$CDXS
Common Stock
2022-06-14+11,273→ 33,974 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-03-23+737,179→ 737,179 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-15$7.63/sh−8,698→ 120,430 total
Award
CODEXIS, INC.$CDXS
Common Stock
2021-06-15+4,796→ 22,701 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-03-26+92,365→ 92,365 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-26+24,866→ 127,440 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$38.14/sh−6,164→ 102,574 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-13$42.00/sh−11,031→ 108,370 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-13−11,031→ 579,959 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-13$2.27/sh+11,031→ 119,401 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-12−24,233→ 590,990 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-12$2.27/sh+24,233→ 132,603 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-12$42.00/sh−24,233→ 108,370 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-09−30,199→ 615,223 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-09$2.27/sh+30,199→ 147,879 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-09$41.00/sh−39,509→ 108,370 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-08$41.00/sh−5,065→ 117,680 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-08−5,065→ 645,422 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-08$2.27/sh+5,065→ 122,745 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-06−35,264→ 650,487 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-06$2.27/sh+35,264→ 161,536 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-06$40.00/sh−44,574→ 117,680 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-08-13$2.27/sh+32,451→ 126,272 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-08-13−32,451→ 685,751 total
Award
CODEXIS, INC.$CDXS
Common Stock
2020-06-16+17,905→ 17,905 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-03-18+109,600→ 109,600 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-18+30,800→ 93,821 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-16$19.19/sh−3,750→ 63,021 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2019-09-18−21,067→ 718,202 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-18$2.27/sh+21,067→ 87,134 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-18$32.13/sh−21,067→ 66,067 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-17$32.11/sh−22,503→ 66,067 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-17$2.27/sh+22,503→ 88,570 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2019-09-17−22,503→ 739,269 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-16$2.27/sh+5,257→ 71,324 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2019-09-16−5,257→ 761,772 total

Companies

Recent Filings

Address

C/O CODEXIS, INC. 200 PENOBSCOT DRIVE

REDWOOD CITY, CA, 94063

View on SEC.gov